Cargando…
A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2
BACKGROUND: Both the map3 Cellular Allogeneic Bone Graft® and recombinant human bone morphogenetic protein 2 (rhBMP-2, Infuse®) were developed to provide an alternative to iliac crest autograft, thus eliminating the morbidity associated with its harvest. The recent literature concerning adverse even...
Autores principales: | Lee, Daniel Dongwhan, Kim, John Yongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574155/ https://www.ncbi.nlm.nih.gov/pubmed/28841904 http://dx.doi.org/10.1186/s13018-017-0618-8 |
Ejemplares similares
-
Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis
por: Roh, Jeffrey S, et al.
Publicado: (2013) -
Fusion Rates of Lateral Lumbar Interbody Fusion Using Recombinant Human Bone
Morphogenetic Protein-2
por: Nourian, Ardalan A., et al.
Publicado: (2018) -
A Retrospective Analysis of Complications Associated With Bone Morphogenetic Protein 2 in Anterior Lumbar Interbody Fusion
por: Hindoyan, Kevork, et al.
Publicado: (2017) -
Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process
por: LoGuidice, Amanda, et al.
Publicado: (2016) -
Allograft Cellular Bone Matrix in Extreme Lateral Interbody Fusion: Preliminary Radiographic and Clinical Outcomes
por: Tohmeh, Antoine G., et al.
Publicado: (2012)